to Treatments
ABOUT US
We are a drug discovery company that is uniquely harnessing the power of protein dynamics, biophysics, machine learning and computational chemistry.
Traditional drug design is limited
At Congruence, we are able to move beyond historically static drug discovery processes towards truly predictive models where the pathogenesis of disease can be corrected in silico at unprecedented speed and accuracy.
Recent Press Releases
Congruence Announces Participation at the 2026 Bloom Burton & Co. Healthcare Investor Conference
https://www.prnewswire.com/news-releases/congruence-announces-participation-at-the-2026-bloom-burton--co-healthcare-investor-conference-302747214.html
Congruence Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
https://www.prnewswire.com/news-releases/congruence-announces-participation-in-the-25th-annual-needham-virtual-healthcare-conference-302738712.html?tc=eml_cleartime
Ground-breaking
discovery engine
Revenir™ allows us to see proteins as others can’t – in their full and dynamic state. We generate and capture the biophysical properties of the full spectrum of protein shapes, an ensemble of protein conformers, derived from a single amino acid sequence.